Home » Topics » BioWorld Science

BioWorld Science
RSS

Elan acquires rights to diazepam gel formulation

June 7, 1996

Trials expected to begin on CoCensys' CCD-1042

June 7, 1996

Genzyme Transgenics and Boehringer Mannheim reach agreement

June 7, 1996

Neoprobe and Dow enter licensing agreement

June 7, 1996

Therapeutic Antibodies seeks London Stock Exchange listing

June 7, 1996

Research agreement: TCPI and the University of Kansas

June 7, 1996

CompuMed and the University of Massachusetts Medical Center enter agreement

June 7, 1996

Patient enrollment for Alkermes' RMP-7 trials complete

June 7, 1996

Pharmacopeia and Akzo Nobel: Drug discovery collaboration

June 7, 1996

Pfizer reports neuroleptics

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...